Search results
Results from the WOW.Com Content Network
The Tandem Diabetes Care t:Slim X2 was approved by the U.S. Food and Drug Administration in 2019 and is the first insulin pump to be designated as an alternate controller enabled (ACE) insulin pump. ACE insulin pumps allow users to integrate continuous glucose monitors, automated insulin dosing (AID) systems, and other diabetes management ...
The FDA approved a tool to update the software on Tandem's pumps in July 2016. The Tandem Device Updater would be used to deliver all software updates to Tandem's pumps moving forward and that the first use of the new tool will be to update t:slim pumps which were shipped prior to April 2015 with a new version of the firmware which speeds the ...
For premium support please call: 800-290-4726 more ways to reach us
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7 [21] [22] [23]; Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps.
For premium support please call: 800-290-4726 more ways to reach us
The FDA has issued a statement following the Class I recall for an IOS app used in conjunction with insulin pumps after 224 injuries were reported.
Insulin pump in use Diabetic child wearing a state-of-the-art insulin pump (referred to as a "patch pump"). His waterproof device needs no one infusion set. An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy.
Different types of pumps are suitable for different applications, for example: a pump's maximum lift height also determines the applications it can be used for. Low-lift pumps are only suitable for the pumping of surface water (e.g., irrigation, drainage of lands, ...), while high-lift pumps allow deep water pumping (e.g., potable water pumping ...